Orenstein, Robert
Mayo Clinic Hospital
7 papers on CoChatORCID 0000-0001-5210-1258
Most cited papers
- Verified
The epidemiology of community-acquired Clostridium difficile infection: a population-based study
Khanna, S., Pardi, D. S., Aronson, S. L., Kammer, P. P., Orenstein, R., St Sauver, J. L., Harmsen, S. W., & Zinsmeister, A. R. (2012) · American Journal of Gastroenterology
Clostridium difficile and Clostridium perfringens researchInfection Control in Healthcare
Cited by 622
- Verified
Safety and Durability of RBX2660 (Microbiota Suspension) for Recurrent Clostridium difficile Infection: Results of the PUNCH CD Study
Orenstein, R., Dubberke, E., Hardi, R., Ray, A., Mullane, K., Pardi, D. S., & Ramesh, M. S. (2016) · Clinical Infectious Diseases
Clostridium difficile and Clostridium perfringens researchGut microbiota and health
Cited by 197
- Verified
Prolonged use of a proton pump inhibitor reduces microbial diversity: implications for Clostridium difficile susceptibility
Seto, C. T., Jeraldo, P., Orenstein, R., Chia, N., & DiBaise, J. K. (2014) · Microbiome
Clostridium difficile and Clostridium perfringens researchGut microbiota and health
Cited by 163
- Verified
Results from a randomized placebo-controlled clinical trial of a RBX2660-a microbiota-based drug for the prevention of recurrent Clostridium difficile infection
Dubberke, E. R., Lee, C. H., Orenstein, R., Khanna, S., Hecht, G., & Gerding, D. N. (2018) · Clinical Infectious Diseases
Clostridium difficile and Clostridium perfringens researchGut microbiota and health
Cited by 140
- Verified
Implementation of a multisite, interdisciplinary remote patient monitoring program for ambulatory management of patients with COVID-19
Coffey, J. D., Christopherson, L. A., Glasgow, A. E., Pearson, K. K., Brown, J. K., Gathje, S. R., Sangaralingham, L. R., Carmona Porquera, E. M., Virk, A., Orenstein, R., et al. (2021) · npj Digital Medicine
Telemedicine and Telehealth ImplementationCOVID-19 Clinical Research Studies
Cited by 61
- Verified
Association of a remote patient monitoring (RPM) program with reduced hospitalizations in cancer patients with COVID-19
Pritchett, J. C., Borah, B. J., Desai, A. P., Xie, Z., Saliba, A. N., Leventakos, K., Coffey, J. D., Pearson, K. K., Speicher, L. L., Orenstein, R., et al. (2021) · JCO Oncology Practice
Telemedicine and Telehealth ImplementationCOVID-19 and healthcare impacts
Cited by 32
- Verified
Treatment of Recurrent Vulvovaginal Candidiasis With Ibrexafungerp
Grant, L. M., & Orenstein, R. (2022) · Journal of Investigative Medicine High Impact Case Reports
Antifungal resistance and susceptibilityReproductive tract infections research
Cited by 7
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free